Peter J. Pronovost, MD, PhD, FCCM
Peter J. Pronovost, MD, PhD, FCCM
Chief Quality & Clinical Transformation Officer
Veale Distinguished Chair in Leadership and Clinical Transformation
Peter Pronovost, MD, PhD, FCCM, is a world-renowned patient safety champion, physician executive, critical care physician, prolific researcher with more than 1000 peer-reviewed publications, an innovator who has founded several technology companies and a thought leader informing U.S. and global health policy.
Dr. Pronovost’s transformative work leveraging checklists to reduce central line-associated bloodstream infections has saved thousands of lives and earned him national acclaim. This life-saving intervention has been implemented across the U.S., and as a result, central line-associated infections that used to kill as many people as breast or prostate cancer have been reduced by 80 percent. In recognition of this innovation, his highest-profile accolades include being named one of the 100 most influential people in the world by Time Magazine and receiving a coveted MacArthur Foundation “genius grant.”
While serving as Chief Clinical Transformation Officer at University Hospitals Health System in Cleveland and as a Professor in the Schools of Medicine, Nursing and Management at Case Western Reserve University, Dr. Pronovost developed a checklist to make visible defects in value and deployed a management and accountability system to eliminate those defects. This system reduced the annual cost of care for Medicare patients by 30% over three years while improving quality. In 2022, Dr. Pronovost lead the efforts that culminated in University Hospitals winning the American Hospital Association’s Quest for Quality award, the industry’s most prestigious honor recognizing its member organizations for their commitment to quality. He was named the Veale Distinguished Chair in Leadership and Clinical Transformation in 2023.
Along with the deputy secretary of Health and Human Services (HHS), Dr. Pronovost co-chaired the Healthcare Quality Summit, an initiative created in response to President Donald Trump’s White House Executive Order to modernize and improve quality measures for HHS, Veterans Affairs and Department of Defense. Dr. Pronovost also serves as a member of the Presidents Council for Science and Technology Patient Safety Working Group that is producing recommendations for improving safety to President Joseph Biden.
Dr. Pronovost previously served as Johns Hopkins Medicine Senior Vice President for Patient Safety and Quality and was the founder and director of the Johns Hopkins Medicine Armstrong Institute for Patient Safety and Quality. He also served as the Senior Vice President for Clinical Strategy and Chief Medical Officer for UnitedHealthcare.
Dr. Pronovost was elected to the National Academy of Medicine in 2011, to the American Academy of Nursing, and has received multiple honorary degrees. He is an advisor to the World Health Organization’s World Alliance for Patient Safety and regularly addresses the U.S. Congress on patient safety issues. He is a founder of VisICU, a tele ICU company purchased by Philips; and Doctella, a health information platform for remote patient monitoring purchased by Masimo. He is a strategic advisor for several health care technology and venture capital companies. Today, he is known as one of the most influential executives and physician leaders in health care and one of the Top 25 innovators in health care.